Managing acne vulgaris effectively

Australian Family Physician

Volumn 35, Issue 9, 2006, Pages 705-708

  Goodman, Greg ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIINFECTIVE AGENT; AZELAIC ACID; BENZOYL PEROXIDE; DERMATOLOGICAL AGENT; DICARBOXYLIC ACID; HYDROXYACID; ISOTRETINOIN; KERATIN; KERATOLYTIC AGENT; ORAL CONTRACEPTIVE AGENT; RETINOID;

ACNE VULGARIS; ADOLESCENT; ADULT; CHILD; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; ORAL DRUG ADMINISTRATION; PHOTOTHERAPY; REVIEW; SEBUM; SECRETION; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANDROGENS; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; CHILD; CONTRACEPTIVES, ORAL; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXY ACIDS; ISOTRETINOIN; KERATINS; KERATOLYTIC AGENTS; MALE; PHOTOTHERAPY; RETINOIDS; SEBUM; TREATMENT OUTCOME;

EID: 84883101192     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Plewig G, Braun-Falco O. Kinetics of epidermis and adnexa following vitamin A acid in the human. Acta Derm Venereol Suppl 1975;74:87-98.
2. Oh CW, Myung KB. An ultrastructural study of the retention hyperkeratosis of experimentally induced comedones in rabbits: the effects of three comedolytics. J Dermatol 1996;23:169-80.
3. Gibson JR. Rationale for the development of new topical treatments for acne vulgaris. Cutis 1996;57:13-19.
4. Shalita A. Topical acne therapy. Dermatol Clin 1983;1:399-403.
5. Brogden RN, Goa KE. Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 1997;53:511-9.
6. Shalita A, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol 1996;34:482-5.
7. Bojar RA, Holland KT, Cunliffe WJ. The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37. J Antimicrob Chemother 1991;28:843-53.
8. Katsambas A, Graupe K, Stratigos J. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris: comparison with vehicle and topical tretinoin. Acta Derm Venereol 1989;143(Suppl):35-9.
9. Graupe K, Cunliffe WJ, Gollnick HP, Zaumseil RP. Efficacy and safety of topical azelaic acid (20% cream): an overview of results from European clinical trials and experimental reports. Cutis 1996;57(1 Suppl):20-35.
10. Van Scott EJ, Yu RJ. Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acid. J Am Acad Dermatol 1984;11:867-79.
11. Wang CM, Huang CL, Hu CT, Chan HL. The effect of glycolic acid on the treatment of acne in Asian skin. Dermatol Surg 1997;23:23-9.
12. Leyden JJ, Hickman JG, Jarratt MT, Stewart DM, Levy SF. The efficacy and safety of a combination benzoyl peroxide/ clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J Cutan Med Surg 2001;5:37-42.
13. Chalker DK, Shalita A, Smith JG Jr, Swann RW. A double blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 1983;9:933-6.
14. Thomas DR, Raimer S, Smith EB. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 solution in the treatment of acne vulgaris. Cutis 1982;29:628-32.
15. Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: Combined results of two double blind investigations. J Am Acad Dermatol 1997;37:590-5.
16. Thiim M, Friedman LS. Hepatotoxicity of antibiotics and antifungals. Clin Liver Dis 2003;7:381-99.
17. Vartiainen M, de Gezelle H, Broekmeulen CJ. Comparison of the effect on acne with a combiphasic desogestrel containing oral contraceptive and a preparation containing cyproterone acetate. Eur J Contracept Reprod Health Care 2001;6:46-53.
18. Vree ML, Schmidt J. A large observational clinical evaluation of a desogestrel containing combiphasic oral contraceptive in Germany. Eur J Contracept Reprod Health Care 2001;6:108-14.
19. Lucky AW, Henderson TA, Olson WH, et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol 1997;37:746-54.
20. Shaw JC. Spironolactone in dermatologic therapy. J Am Acad Dermatol 1991;24:236-43.
21. Lee O, Farquhar C, Toomath R, Jepson R. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 2000;(2): CD000194.
22. Wang HS, Wang TH, Soong YK. Low dose flutamide in the treatment of acne vulgaris in women with or without oligomenorrhea or amenorrhea. Changgeng Yi Xue Za Zhi 1999;22:423-32.
23. Wolff H. Finasteride: also effective in acne vulgaris?. Hautarzt 1999;50:815.
24. Amichai B, Grunwald MH, Sobel R. 5 alpha-reductase inhibitors: a new hope in dermatology?. Int J Dermatol 1997;36:182-4.
25. Orfanos CE, Zopuboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology. Drugs 1997;53:358-88.
26. White GM, Chen W, Yao J, Wolde-Tsadik G. Recurrence rates after the first course of isotretinoin. Arch Dermatol 1998;134:376-8.
27. Allison MA, Dunn CL, Person DA. Acne fulminans treated with isotretinoin and 'pulse' corticosteroids. Pediatr Dermatol 1997;14:39-42.
28. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001;45:515-9.
29. Wysowski DK, Pitts M, Beitz J. Depression and suicide in patients treated with isotretinoin. N Engl J Med 2001;344:460.
30. Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 1995;55:165-8.
31. Bershad S, Rubinstein A, Paterniti JR, et al. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med 1985;313:981-5.
32. Milstone LM, McGuire J, Ablow RC. Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. J Am Acad Dermatol 1982;7:663-6.
33. Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T. Acne phototherapy with a high intensity, enhanced, narrow band, blue light source: an open study and in vitro investigation. J Dermatol Sci 2002;30:129-35.
34. Goldman MP, Boyce SM. A single center study of aminolevulinic acid and 417 NM photodynamic therapy in the treatment of moderate to severe acne vulgaris. J Drugs Dermatol 2003;2:393-6.
35. Seaton ED, Charakida A, Mouser PE, Grace I, Clement RM, Chu AC. Pulsed dye laser treatment for inflammatory acne vulgaris: randomised controlled trial. Lancet 2003;25;362:1347-52.
36. Charakida A, Seaton ED, Charakida M, Mouser P, Avgerinos A, Chu AC. Phototherapy in the treatment of acne vulgaris: what is its role?. Am J Clin Dermatol 2004;5:211-6.
37. Elman M, Lebzelter J. Light therapy in the treatment of acne vulgaris. Dermatol Surg 2004;30:139-46.